2,580 results on '"AMYOTROPHIC lateral sclerosis"'
Search Results
2. Yamaguchi University Graduate School of Medicine Researchers Illuminate Research in Amyotrophic Lateral Sclerosis [Establishment of a novel amyotrophic lateral sclerosis patient (TARDBPN345K/+)-derived brain microvascular endothelial cell model ...]
3. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis
4. University of Edinburgh Researcher Advances Knowledge in Amyotrophic Lateral Sclerosis (Neuronal Circuit Dysfunction in Amyotrophic Lateral Sclerosis)
5. Data on Gene Therapy Detailed by Researchers at Department of Neurology (Current potential therapeutics of amyotrophic lateral sclerosis)
6. Patent Issued for S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis (USPTO 11938102)
7. Patent Issued for Treatment of amyotrophic lateral sclerosis (ALS) (USPTO 11931375)
8. Institute for Cancer Research and Treatment (IRCCS) Foundation Santa Lucia Researchers Have Provided New Data on Amyotrophic Lateral Sclerosis (Endurance exercise has a negative impact on the onset of SOD1-G93A ALS in female mice and affects ...)
9. UK Dementia Research Institute at King's College London Researcher Yields New Data on Amyotrophic Lateral Sclerosis (Synaptopathy: presynaptic convergence in frontotemporal dementia and amyotrophic lateral sclerosis)
10. New Amyotrophic Lateral Sclerosis Data Has Been Reported by a Researcher at University of Patras (Novel Pathogenic Variants Leading to Sporadic Amyotrophic Lateral Sclerosis in Greek Patients)
11. Patent Application Titled '(2s)-2-Aminopentanethioic S-acid for use as medicament and in therapy of amyotrophic lateral sclerosis' Published Online (USPTO 20240058285)
12. Establishment of a novel amyotrophic lateral sclerosis patient-derived blood-brain barrier model: Investigating barrier dysfunction and immune cell interaction
13. 'Therapeutic Pharmaceutical Composition For Amyotrophic Lateral Sclerosis' in Patent Application Approval Process (USPTO 20240010735)
14. Macquarie University Researcher Furthers Understanding of Amyotrophic Lateral Sclerosis (Novel small molecules therapeutics for FTD/ALS reduce TDP43 related pathology)
15. Improving Care for Amyotrophic Lateral Sclerosis with Artificial Intelligence and Affective Computing
16. 'Biomarkers For Amyotrophic Lateral Sclerosis Stratification' in Patent Application Approval Process (USPTO 20240327917)
17. University of Yamanashi Researchers Provide New Insights into Amyotrophic Lateral Sclerosis (Current progress in microRNA profiling of circulating extracellular vesicles in amyotrophic lateral sclerosis: A systematic review)
18. Research from NeuroMuscular Research Center in Amyotrophic Lateral Sclerosis Provides New Insights (Quantitative susceptibility mapping as an early neuroimaging biomarker for amyotrophic lateral sclerosis: A review)
19. Prince Sultan Military Medical City Researchers Have Provided New Data on Amyotrophic Lateral Sclerosis (Multiple sclerosis and amyotrophic lateral sclerosis: is there an association or a red flag? A case report and literature review)
20. Patent Application Titled 'Fibroblast Based Therapeutics Of Amyotrophic Lateral Sclerosis' Published Online (USPTO 20240269192)
21. New Amyotrophic Lateral Sclerosis Data Has Been Reported by a Researcher at University of Arkansas at Fayetteville (Exercise training induces mild skeletal muscle adaptations without altering disease progression in a TDP-43 mouse model)
22. DJ-1 products glycolic acid and D-lactate restore deficient axonal trafficking and DNA damage response in FUS and SOD1-associated amyotrophic lateral sclerosis
23. Dysregulated actin dynamics and cofilin correlate with TDP-43 pathology in sporadic amyotrophic lateral sclerosis
24. Specific Bacterial Taxa and Their Metabolite, DHPS, Linked to Alzheimers Disease, Parkinsons Disease, and Amyotrophic Lateral Sclerosis
25. Researchers at Boise State University Release New Data on Amyotrophic Lateral Sclerosis (Airway Clearance Strategies and Secretion Management In Amyotrophic Lateral Sclerosis)
26. Research from Seoul National University College of Medicine in the Area of Amyotrophic Lateral Sclerosis Described (Individualized predictions for clinical milestone in amyotrophic lateral sclerosis: A multialgorithmic approach)
27. Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis
28. New Findings from Macquarie University in the Area of Gene Therapy Described (Targeting 14-3-3 0-mediated Tdp-43 Pathology In Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Mice)
29. New Amyotrophic Lateral Sclerosis Study Findings Have Been Reported by a Researcher at Department of Nutrition Exercise and Sports (Characterization of the skeletal muscle arginine methylome in health and disease reveals remodeling in ...)
30. Researcher at University of Medicine Targets Amyotrophic Lateral Sclerosis (Exploring the Role of Metabolic Hormones in Amyotrophic Lateral Sclerosis)
31. Massachusetts Institute of Technology Researchers Detail Findings in Amyotrophic Lateral Sclerosis (Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls)
32. A panel of TDP-43-regulated splicing events verify loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue (Updated May 11, 2023)
33. 'Use Of Mirna-485 Inhibitors For Treating Amyotrophic Lateral Sclerosis (Als)' in Patent Application Approval Process (USPTO 20230131083)
34. Researchers Submit Patent Application, 'Low Dose Human Interleukin-2 For The Treatment Of Amyotrophic Lateral Sclerosis', for Approval (USPTO 20230090069)
35. Reports from Ulster University Advance Knowledge in Amyotrophic Lateral Sclerosis (Extracellular Vesicles in Amyotrophic Lateral Sclerosis)
36. Intracellular conformation of amyotrophic lateral sclerosis-causative TDP-43
37. Researcher from National Scientific and Technical Research Council (CONICET) Publishes Findings in Amyotrophic Lateral Sclerosis (Testosterone Reduces Myelin Abnormalities in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis)
38. Data from Tallahassee Update Knowledge in Amyotrophic Lateral Sclerosis (Factors Affecting Performance on a Screening Tool in Persons with Amyotrophic Lateral Sclerosis)
39. Researchers from Tbilisi State Medical University Publish Findings in Amyotrophic Lateral Sclerosis [Analysis of C9orf72 repeat expansions in Georgian patients with Amyotrophic lateral sclerosis (ALS) [version 2; peer review: 2 approved]]
40. University of Tasmania Researcher Publishes Findings in Amyotrophic Lateral Sclerosis (How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?)
41. Genomics Research Center Researcher Adds New Findings in the Area of Amyotrophic Lateral Sclerosis (Sulfated disaccharide protects membrane and DNA damages from arginine-rich dipeptide repeats in ALS)
42. Data from Shanghai Jiao Tong University School of Medicine Broaden Understanding of Amyotrophic Lateral Sclerosis (Metformin ameliorates the mitochondrial damage induced by C9ORF72 amyotrophic lateral sclerosis/frontotemporal dementia-related ...)
43. New Amyotrophic Lateral Sclerosis Data Have Been Reported by Investigators at Johns Hopkins University (A Fluid Biomarker Reveals Loss of Tdp-43 Splicing Repression In Presymptomatic Als-ftd)
44. Data from National Rehabilitation Center Update Knowledge in Amyotrophic Lateral Sclerosis (Experiences of an Online Palliative Rehabilitation Programme for Spousal Caregivers of People With Amyotrophic Lateral Sclerosis and Cognitive and/or ...)
45. Investigators from China Medical University Have Reported New Data on Amyotrophic Lateral Sclerosis (Fluvoxamine Exerts Sigma-1r To Rescue Autophagy Via Pom121-mediated Nucleocytoplasmic Transport of Tfeb)
46. Differential expression of RPS6KA6 in amyotrophic lateral sclerosis. (Updated December 28, 2022)
47. Differential expression of UBB in amyotrophic lateral sclerosis. (Updated December 25, 2022)
48. Differential expression of ZNF382 in amyotrophic lateral sclerosis. (Updated December 25, 2022)
49. Differential expression of MUSK in amyotrophic lateral sclerosis
50. Differential expression of SLC7A6 in amyotrophic lateral sclerosis. (Updated December 28, 2022)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.